Mivacurium
Back to searchMolecule Structure
Scientific Name
Mivacurium
Description of the Drug
Mivacurium is a short-acting non-depolarizing neuromuscular blocking agent used to induce anesthesia during intubation and promote skeletal muscle relaxation during surgery or mechanical ventilation.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01226
http://www.drugbank.ca/drugs/DB01226
Brand Name(s)
Not Available
Company Owner(s)
Abbvie Inc, Rising Pharma Holding Inc, Woodward Pharma Services Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Muscle-type nicotinic acetylcholine receptor | PROTEIN COMPLEX GROUP | ANTAGONIST | CHEMBL2362997 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL10014476 | ||
| PharmGKB | PA450528 | ||
| Human Metabolome Database | HMDB0015357 | ||
| DrugBank | DB01226 | ||
| PubChem: Thomson Pharma | 14816757 | ||
| PubChem | 5281042 | ||
| Nikkaji | J283.273I | ||
| EPA CompTox Dashboard | DTXSID6048333 | ||
| DrugCentral | 1822 | ||
| Guide to Pharmacology | 7243 | ||
| rxnorm | MIVACRON | MIVACURIUM | MIVACURIUM CHLORIDE |
| KEGG Ligand | C07550 | ||
| ChEBI | 6958 | ||
| ZINC | ZINC000150338702 |
